cancer from semaglutide Frontiers GLP-1 Weight Loss Drugs Linked

97, Boca Raton: CRC Press, 2016, ISBN 978-1-4987-5429-3, OCLC 961861918 (ang.)

Complicated gallstone disease Complications can occur in a subgroup of gallstones patients at the level of the gallbladder, biliary tract, pancreas, and intestine

Zepbound, from drugmaker Eli Lilly, belongs to a new class of medications, called GLP-1 agonists, that have skyrocketed in popularity in the U.S

However, some individuals develop non-alcoholic steatohepatitis (NASH) , where inflammation and liver cell damage occur alongside fat accumulation, potentially progressing to fibrosis, cirrhosis, or liver failure

Tordai, D

2012;97(9):E1677E1685